Circulate Health is pioneering technologies to improve healthspan and reduce biological age. The firm is dedicated to harnessing the potential of therapeutic plasma exchange (TPE) to advance human healthspan and lifespan.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/02/25 | $12,000,000 | Seed |
CSC Venture Capital Khosla Ventures  Seaside Ventures | undisclosed |
